Literature DB >> 15226522

Objective psychological measurement and clinical assessment of anxiety in adverse drug reactions.

Debra Ong1, Alpa Popat, Sandra R Knowles, John S Arrowood, Neil H Shear, Karen E Binkley.   

Abstract

BACKGROUND: A confounding factor in the diagnosis of adverse drug reactions (ADRs) is the psychological state of the patient. Patients with underlying anxiety and related disorders may present with psychogenic reactions, which involve physiologic responses originating from psychological, rather than organic factors.
OBJECTIVE: To examine the contribution of anxiety and related disorders to adverse drug events.
METHODS: Participants from an adverse drug reaction clinic completed the Trauma Symptom Checklist-40 (TSC-40), a 40-item questionnaire consisting of six subscales: anxiety, depression, dissociation, sexual abuse trauma index (SATI), sexual problems, and sleep disturbance. Physicians assessed the likelihood that adverse events were due to anxiety or drug(s) by providing an anxiety score (0 to 10) and an ADR score (0 to 10), respectively, for each participant.
RESULTS: Patients clinically assessed as having "high anxiety" (anxiety score 7-10 and ADR score 0-3; n = 11) scored higher than patients clinically assessed as having a "true ADR" (anxiety score 0-3 and ADR score 7-10; n = 19) on the TSC-40 total (P = 0.006) as well as anxiety (P = 0.012), depression (P = 0.007), and SATI subscales (P = 0.016).
CONCLUSION: This study is the first to use a validated psychological measurement to indicate that a substantial percentage of reported adverse drug events may in fact be a manifestation of underlying anxiety and/or related disorders. We suggest that mechanisms of symptom generation may be analogous to those operative in idiopathic environmental intolerance.

Entities:  

Mesh:

Year:  2004        PMID: 15226522

Source DB:  PubMed          Journal:  Can J Clin Pharmacol        ISSN: 1198-581X


  4 in total

1.  Allergy and psychologic evaluations of patients with multiple drug intolerance syndrome.

Authors:  Tiziana De Pasquale; Eleonora Nucera; Rocco Boccascino; Petronilla Romeo; Giuseppe Biagini; Alessandro Buonomo; Amira Colagiovanni; Valentina Pecora; Arianna Aruanno; Angela Rizzi; Carla Lombardo; Vito Sabato; Giovanni Gasbarrini; Giampiero Patriarca; Domenico Schiavino
Journal:  Intern Emerg Med       Date:  2011-01-23       Impact factor: 3.397

2.  [Patients with adverse drug reactions have a higher prevalence of emotional disorders].

Authors:  Elizabeth Gutiérrez-Islas; Brenda Beatriz Báez-Montiel; José Luis Turabián; Margarita Bolaños-Maldonado; Juan Ramón Herrera-Ontañón; Alejandro Villarín Castro; Francisco López de Castro
Journal:  Aten Primaria       Date:  2012-09-11       Impact factor: 1.137

3.  Role of personality traits in reporting the development of adverse drug reactions: a prospective cohort study of the Estonian general population.

Authors:  Anu Realo; Henriët van Middendorp; Liisi Kööts-Ausmees; Jüri Allik; Andrea W M Evers
Journal:  BMJ Open       Date:  2018-07-10       Impact factor: 2.692

4.  Psychological profiles of patients with suspected drug allergy.

Authors:  Eunice Dias de Castro; Ana Leblanc; Joselina Barbosa; Laura Ribeiro; Josefina R Cernadas
Journal:  Asia Pac Allergy       Date:  2020-10-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.